chr2-21015495-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000384.3(APOB):​c.3383G>A​(p.Arg1128His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00455 in 1,614,006 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1128C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0038 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 25 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

1
1
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:13

Conservation

PhyloP100: 0.144

Publications

27 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007625997).
BP6
Variant 2-21015495-C-T is Benign according to our data. Variant chr2-21015495-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 281142.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.3383G>Ap.Arg1128His
missense
Exon 22 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.3383G>Ap.Arg1128His
missense
Exon 22 of 29ENSP00000233242.1P04114
APOB
ENST00000673739.2
n.*2689G>A
non_coding_transcript_exon
Exon 21 of 25ENSP00000501110.2A0A669KB70
APOB
ENST00000673882.2
n.*2478G>A
non_coding_transcript_exon
Exon 20 of 23ENSP00000501253.2A0A669KB70

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
573
AN:
152048
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00439
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00769
Gnomad FIN
AF:
0.00208
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00590
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00378
AC:
949
AN:
251360
AF XY:
0.00412
show subpopulations
Gnomad AFR exome
AF:
0.000861
Gnomad AMR exome
AF:
0.00379
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00185
Gnomad NFE exome
AF:
0.00442
Gnomad OTH exome
AF:
0.00603
GnomAD4 exome
AF:
0.00463
AC:
6764
AN:
1461840
Hom.:
25
Cov.:
33
AF XY:
0.00464
AC XY:
3373
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33480
American (AMR)
AF:
0.00371
AC:
166
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00605
AC:
522
AN:
86258
European-Finnish (FIN)
AF:
0.00227
AC:
121
AN:
53374
Middle Eastern (MID)
AF:
0.00676
AC:
39
AN:
5768
European-Non Finnish (NFE)
AF:
0.00502
AC:
5577
AN:
1112004
Other (OTH)
AF:
0.00505
AC:
305
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
407
814
1222
1629
2036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00377
AC:
573
AN:
152166
Hom.:
3
Cov.:
32
AF XY:
0.00337
AC XY:
251
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.000747
AC:
31
AN:
41522
American (AMR)
AF:
0.00438
AC:
67
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.00790
AC:
38
AN:
4808
European-Finnish (FIN)
AF:
0.00208
AC:
22
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00590
AC:
401
AN:
67994
Other (OTH)
AF:
0.00569
AC:
12
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00446
Hom.:
10
Bravo
AF:
0.00364
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00477
AC:
41
ExAC
AF:
0.00371
AC:
450
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00583
EpiControl
AF:
0.00492

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
not provided (5)
-
2
1
Hypercholesterolemia, autosomal dominant, type B (3)
-
-
3
Hypercholesterolemia, familial, 1 (3)
-
-
2
not specified (2)
-
1
-
APOB-related disorder (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypercholesterolemia (1)
-
1
-
Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
21
DANN
Pathogenic
1.0
Eigen
Benign
-0.020
Eigen_PC
Benign
0.045
FATHMM_MKL
Benign
0.75
D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-0.77
T
PhyloP100
0.14
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.18
Sift
Benign
0.096
T
Sift4G
Uncertain
0.0020
D
Vest4
0.37
MVP
0.53
MPC
0.043
ClinPred
0.021
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
gMVP
0.53
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12713843; hg19: chr2-21238367; COSMIC: COSV51927392; API